Haywood George Weaver Acquired Stake in Neptune Technologies & Bioressources Inc

February 14, 2018 - By Stephen Andrade

 Haywood George Weaver Acquired Stake in Neptune Technologies & Bioressources Inc

Investors sentiment increased to 1.6 in 2017 Q3. Its up 0.82, from 0.78 in 2017Q2. It is positive, as 2 investors sold Neptune Technologies & Bioressources Inc. shares while 3 reduced holdings. 3 funds opened positions while 5 raised stakes. 8.49 million shares or 5.81% less from 9.02 million shares in 2017Q2 were reported.

Northwest Invest Counselors Ltd Limited Liability Company stated it has 95,664 shares. Retail Bank Of America De has invested 0% in Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT). Perceptive Advsr has invested 0.16% in Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT). Ig Invest Ltd invested 0% of its portfolio in Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT). Financial Bank Of Montreal Can reported 5,223 shares. Morgan Stanley stated it has 35,144 shares or 0% of all its holdings. Natl Asset Inc owns 35,000 shares. Deutsche State Bank Ag invested in 0% or 200 shares. Grp One Trading L P holds 0% or 400 shares. Lpl Finance Ltd Liability invested 0% of its portfolio in Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT). Cohen Capital Management holds 0% in Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) or 14,232 shares. Creative Planning holds 0% or 15,529 shares in its portfolio. Royal Comml Bank Of Canada, Ontario – Canada-based fund reported 16,681 shares. Tower Research Capital Ltd Limited Liability Company (Trc) has 0% invested in Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) for 4,800 shares. 15 are owned by Credit Agricole S A.

The New Haywood George Weaver Holding in Neptune Technologies & Bioressources Inc

Haywood George Weaver reported SC 13G/A form with the SEC for Neptune Technologies & Bioressources Inc. Access it here: 000114420418007929. As reported by Haywood George Weaver, the filler owns 9% or 7,063,303 shares of the Health Care–company.

Neptune Technologies & Bioressources Inc stake is new for [reportingPerson]. Date of activity: December31, 2017. This shows Haywood George Weaver’s positive view for Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc Institutional Sentiment

Filings show 29 investors own Neptune Technologies & Bioressources Inc. The ownership in Q3 2015 is low, at Infinity of the outstanding shares. This is increased by 93999. 8413367 were owned by these investors. 5 funds opened new Neptune Technologies & Bioressources Inc stakes, 6 increased positions. There were 5 that closed positions and 9 reduced them.

Concannon Wealth Management Llc is an investor bullish on Neptune Technologies & Bioressources Inc, owning 700 shares as of Q3 2015 for less than 0.01% of its portfolio. Alpine Partners Vi Llc owns 188101 shares or 0.06% of its portfolio. NY Peconic Partners Llc have 0.02% of its portfolio for 104200 shares. Further, Perceptive Advisors Llc reported stake worth 0.59% of its portfolio. The CA Cohen Capital Management Inc owns 14232 shares. Neptune Technologies & Bioressources Inc is less than 0.01% of its portfolio.

Business Profile

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company’s products include Krill-Based Nutraceutical Products, including Neptune Krill Oil (NKO), OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti. The Company’s NKO is a marine oil extracted from krill (Euphasia superba). NKO consists of phospholipids, which contain omega-3 fatty acids, including eicosapentaenoic acid and docosahexaenoic acid (EPA & DHA), and antioxidants, such as astaxanthin, vitamin A and vitamin E. The Company sells OCEANO3 directly to consumers in Canada through its online platform (www.oceano3.com), under its brand name.

SEC Form 13G.

The stock decreased 4.41% or $0.15 during the last trading session, reaching $3.25. About 881,910 shares traded. Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) has risen 3.77% since February 14, 2017 and is uptrending. It has underperformed by 12.93% the S&P500.

Neptune Technologies & Bioressources Inc., a nutrition products company, focuses on providing nutrition solutions, including specialty ingredients and consumer brands. The company has market cap of $253.39 million. The firm develops solutions available in various delivery forms. It has a 49.24 P/E ratio. It also offers various specialty ingredients, including premium krill oil and other marine oils, as well as seed oils.

More notable recent Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) news were published by: Reuters.com which released: “Neptune Technologies Extends Global Maxsimil Licence To Cannabis-Derived Products​” on November 27, 2017, also Fool.com with their article: “Here’s Why Neptune Technologies & Bioressources Inc. Rose as Much as 14% Today” published on February 12, 2018, Reuters.com published: “Neptune And Tetra Bio-Pharma Sign Co-Development Agreement” on February 12, 2018. More interesting news about Neptune Technologies & Bioressources Inc. (NASDAQ:NEPT) were released by: Marketnewscall.com and their article: “Morning Update: Pernix Therapeutics Holdings Inc (NASDAQ:PTX ), Relypsa Inc …” published on June 16, 2016 as well as Reuters.com‘s news article titled: “Neptune Q2 revenue C$6.8 million versus C$11.6 million” with publication date: November 14, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.